aap Posts € 8.0 Million (+36%) in Sales and an EBIT of € 0.7 Million in First Quarter of 2008
aap Implantate AG, a medical technology company listed on the Frankfurt stock exchange and active in biomaterials, fracture healing and joint replacement, achieved in the first three months of fiscal 2008 sales growth of 36% to EUR 8.0 million (previous year: EUR 5.9 million) and an operating result of EUR 0.7 million (previous year: -EUR 0.1 million).
| In EUR million | Q1/2008 | Q1/2007 | Change |
| Sales | 8.0 | 5.9 | +36% |
| EBITDA | 1.5 | 0.4 | +275% |
| EBIT | 0.7 | -0.1 | n/a |
| EBT | 0.5 | -0.2 | n/a |
| net period result | 0.4 | -0.1 | n/a |
| Equity (ratio) | 43.9 (63%) | 43.4 (64%) | +1% |
| Balance Sheet Total | 69.4 | 68.0 | +2% |
| Employees | 295 | 289 | +2% |
Print this page
